Publications by authors named "Ken Wyatt"

Claim this Profile
V
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration.
Albert Thomas, Jessica Finlay, Elizabeth McKinnon, Ken Wyatt

Vet Comp Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence.
Francois Xavier Rwandamuriye, Cameron W Evans, Ben Wylie, Marck Norret, Breana Vitali, Ken Wyatt

Cell Rep Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy.
Stephen Francis Proksch, Clinton Petrus Matthysen, John E Jardine, Ken Mark Wyatt, Jessica Renee Finlay

Vet Comp Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs.
Jaime A Olsen, Maurine Thomson, Kathleen O'Connell, Ken Wyatt

Vet Med Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interview with the Hon. Ken Wyatt: improving Indigenous health outcomes from a political viewpoint.
Ken Wyatt

Public Health Res Pract· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal mast cell tumor in the dog: A case series.
Alison Khoo, Amy Lane, Ken Wyatt

Can Vet J· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis